One of the China’s biggest pharma firms by market value, Jiangsu Hengrui Medicine Co., Ltd., is taking a focused approach for moving its innovative drugs onto the world stage, while other biotechs eyeing global market expansion are already reaching milestones.
Hengrui, which is still relying mainly on generics, should be “positioned as a patented drug company for the Chinese people,”...